News|Videos|September 13, 2023
Interview with Piramal’s Peter DeYoung at DCAT
Author(s)Piramal Pharma Solutions
Advertisement
Key Learning Objectives
- Demonstrate expertise in key areas of drug substance & drug product development and manufacturing with emphasis on APIs and ADCs
- Piramal is expanding to meet current and future market demand
- Piramal is a leader in integrated solutions with 15 sites in NA, EU and India
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Germany Pharma Tariff Threat: What Manufacturers Need to Know
2
Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet
3
Pharma Fundamentals: Hold Times in Biopharmaceuticals
4
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
5